Skip to main content
Clinical Trials/IRCT20211013052758N1
IRCT20211013052758N1RecruitingPhase 1

Evaluating the effects of treatmen with amitriptyline as a tricyclic antidepressant drug on serum prolactin levels in patients with chronic migraine and its relation with patient’s quality of life and function

Semnan University of Medical Sciences0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • patients with migraine without aura who need preservative treatment
  • patients with migraine with classic aura who need preservative treatment

Exclusion Criteria

  • anything that might affect serum prolactin levels in patients including medications or comorbidities
  • contraindications of TCAs prescription such as heart disease or anaphylaxia

Investigators

Sponsor
Semnan University of Medical Sciences

Similar Trials